Status:
COMPLETED
Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders
Lead Sponsor:
ART Fertility Clinics LLC
Conditions:
Anti-Mullerian Hormone Isoforms
Eligibility:
FEMALE
Brief Summary
This study wants to evaluate significant clinical impact of different AMH isoforms in serum can be present or absent in expected poor responder participants. The specific AMH isoforms could therefore ...
Detailed Description
The study has a prospective observational multicentric design and the investigators aim to investigate the presence of AMH isoforms and the levels of Inhibin B in serum among a population of participa...
Eligibility Criteria
Inclusion
- pre-treatment AMH recording below 1.1 ng/ml on day 2 or 3 of the menstrual cycle.
- BMI between 18 and 30 kg/m2.
Exclusion
- Pregnancy.
- Breastfeeding.
- Intake of oral contraceptive pills or steroids for the last two menstrual cycles.
- Endometriosis.
- Previous surgical intervention, which could have an impact on the ovarian reserve, e.g. ovarian cyst removal, removal of one or both tubes, tubal ligation for sterilisation
Key Trial Info
Start Date :
February 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2022
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT03826888
Start Date
February 25 2019
End Date
May 30 2022
Last Update
August 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Middle East Fertility Clinic
Abu Dhabi, United Arab Emirates, 60202